There have been reports (mostly from Japan) of self-injury and delirium with the use of Tamiflu in patients with influenza.
Roche and FDA recently notified doctors of revisions to the Precautions, Neuropsychiatric Events, and Patient Information sections of the prescribing information for Tamiflu.
People with influenza, especially children, may be at an increased risk of self-injury and confusion shortly after taking Tamiflu and should be closely monitored for signs of unusual behavior.
A healthcare professional should be contacted immediately if the patient taking Tamiflu shows any signs of unusual behavior.
Leave a Reply